Insmed Incorporated(INSM)NASDAQ
Stock Performance & Returns
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
INSM | 27.66 B | -29.88x | 2.96% | -76.94% | $-4.24 | -87.22% | 0.98 | - | $212.75 | $90.39 |
NTRA | 47.23 B | -244.53x | 37.70% | -7.11% | $-1.34 | -12.54% | 0.13 | - | $343.18 | $157.43 |
RVMD | 45.20 B | -24.02x | - | - | $-8.78 | -79.09% | 0.46 | - | $224.31 | $37.88 |
ALNY | 35.39 B | 45.45x | 66.90% | 16.13% | $5.82 | 96.56% | 2.21 | - | $495.55 | $197.81 |
BIIB | 33.17 B | 40.16x | 3.40% | 8.32% | $5.59 | 4.58% | 0.44 | - | $222.85 | $133.53 |
Peer Valuation & Performance Analysis
Peer group analysis for Insmed Incorporated (INSM) compared to its primary competitors (including NTRA, RVMD, ALNY) reveals distinct metrics. INSM trades at a valuation premium compared to its competitors, with a P/E ratio of -29.9x versus the peer average of -45.7x (representing a -35% premium). This indicates that the market expects superior growth or commands a quality premium for INSM. In terms of growth, INSM's revenue growth of 3.0% lags behind the peer average of 36.0%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of -76.9% is below the peer average of 5.8%, suggesting higher operational costs or lower pricing power relative to peers.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• INSM ranks #0 in P/E ratio, #4 in revenue growth, and #5 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-09-03 | $126.70 | $127.09 | $124.05 | $126.68 | 1,885,200 | -0.02% |
| 2026-09-02 | $121.11 | $126.79 | $121.11 | $126.63 | 1,998,200 | +4.56% |
| 2026-09-01 | $121.95 | $122.19 | $119.52 | $121.51 | 1,419,300 | -0.36% |
| 2026-08-31 | $118.68 | $122.71 | $117.51 | $121.82 | 2,389,700 | +2.65% |
| 2026-08-28 | $120.11 | $120.66 | $117.15 | $118.54 | 1,977,500 | -1.31% |
| 2026-08-27 | $124.67 | $126.10 | $121.21 | $121.39 | 1,056,100 | -2.63% |
| 2026-08-26 | $122.89 | $125.59 | $121.64 | $124.39 | 1,979,900 | +1.22% |
| 2026-08-25 | $124.65 | $127.18 | $122.87 | $123.89 | 2,373,100 | -0.61% |
| 2026-08-24 | $125.03 | $126.11 | $122.83 | $123.98 | 1,340,900 | -0.84% |
| 2026-08-21 | $125.22 | $127.20 | $124.82 | $125.77 | 1,124,500 | +0.44% |
| 2026-08-20 | $128.36 | $130.27 | $124.60 | $125.08 | 1,761,700 | -2.56% |
| 2026-08-19 | $129.85 | $131.10 | $127.42 | $130.66 | 1,491,100 | +0.62% |
| 2026-08-18 | $128.07 | $128.93 | $126.39 | $128.46 | 1,274,100 | +0.30% |
| 2026-08-17 | $124.71 | $128.46 | $124.70 | $128.32 | 1,899,500 | +2.89% |
| 2026-08-14 | $125.67 | $126.85 | $122.21 | $123.74 | 1,957,200 | -1.54% |
Explore More Analysis for INSM
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.